Table 1.
Demographic data
| Patients without positive ESBL-E sample | ESBL-E referred patients | ESBL-E acquired patients | p | |
|---|---|---|---|---|
| Number | 268 | 25 | 19 | |
| Age (years) | 63 [51–75] | 65 [59–76] | 67 [49–78] | 0.39 a
0.52 b |
| Sex ratio (M/F) | 57 | 48 | 68 | 0.40 a
0.35 b |
| IGS 2 | 38 [27–51] | 42 [33–47] | 42 [36–51] | 0.55 a
0.39 b |
| ICU Mortality (%) | 19 | 16 | 15.7 | 1 a
1 b |
| Length of stay (days) | 4 [3–6] | 7 [6–9] | 12 [8–23] | <0.005a
<0.005 b |
(Age, IGS 2 and length of stay are expressed as medians, acomparison between ESBL-E imported patients and patients without positive ESBL-E cultures, bcomparison between ESBL-E acquired patients and patients without positive ESBL-E cultures)